Look back at pharma news to June 24

26 June 2016

By Barbara Obstoj-Cardwell. Editor

Britain's unexpected vote on Thursday to leave the European Union, which saw currency and stock markets in turmoil in Friday, has left many scrambling to determine the impact on markets and various sectors.

In medicine they talk about triage in making quick decisions to save lives. Central bankers and politicians across Europe will be performing financial triage this weekend on the UK and EU. But big Pharma execs and their financial staffs will also be working overtime to monitor their cash reserves and scrutinize their corporate financial structures, said Steve Brozak writing in Forbes magazine. Corporations like predictability and Brexit represents the antithesis to that order. Pharmaceutical entities will react to this dislocation in a fairly predictable manner, he stated

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK